Anzeige
Mehr »
Login
Donnerstag, 23.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
Amazon investiert Millionen in Kernenergie - so können Sie sich früh positionieren!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
159 Leser
Artikel bewerten:
(1)

IFS announces outstanding 2024 financial results driven by increase in demand for Industrial AI

Finanznachrichten News

IFS surpasses €1 billion ARR reinforcing the company's position as the global leader in Industrial AI

LONDON, Jan. 23, 2025 /PRNewswire/ -- IFS, the leading provider of enterprise cloud and Industrial AI software, today announces its strongest ever financial performance, for the year ending December 31, 2024. Sustained organic global growth fueled by demand for Industrial AI has driven Annual Recurring Revenue (ARR) to exceed €1 billion, with total revenue for the year at €1.228 billion.

IFS FY2024 Key Results:

  • Annual Recurring Revenue increased by 32% YoY
  • Cloud Revenue increased by 38% YoY

The impact of AI within the industrial setting is poised to contribute substantial long-term economic value, which is why companies in the hardcore industries that protect, power, and service the planet are turning to IFS.ai. IFS's significant growth in 2024 reflects this demand, with the company continuing to take market share from legacy vendors.

With more of the world's largest and most respected brands moving to IFS, the company was proud to welcome over 350 new customers, including: Comcast, Electrify America, E.On, Exelon, HomeServe, Miele, Molson Coors, Modulaire Group, Rolls-Royce Power Systems, Saudi Electricity Company, Sureserve Group, Quanta Services and Vattenfall. The customers who are new to IFS are larger businesses, which is reflected in the average deal size of IFS's largest customers increasing by 64% YoY.

IFS's global partner community continues to play a significant role in delivering value to customers, with partner revenue increasing 34% YoY. Organic growth was complemented by the completion of two strategic acquisitions including Copperleaf, the global leader in asset management and asset investment planning (AIP), and?EmpowerMX, an AI-powered aviation maintenance software provider.

Mark Moffat, Chief Executive Officer, IFS commented: "IFS is leading the Industrial AI revolution, evidenced by our sustained financial performance that is fuelled by customer demand for IFS.ai. It is testament to the trust we have built, and I offer my gratitude to our customers and partners for their collaboration, visionary spirit, and confidence in our shared future."

"Our success is a result of strong execution of our industry-focused strategy. No other vendor understands our customers' industries as well as IFS, which simply means that our customers are realizing exceptional value from IFS.ai. We continue to outperform monolithic, legacy enterprise software vendors who have not kept up with the pace of change."

Matthias Heiden, Chief Financial Officer, IFS commented: "Surpassing €1 billion ARR is a significant milestone in the enterprise software industry, reflecting the reliability with which we execute. Cash flow and conversion also grew significantly in the period, meaning business transformation and strategy execution was very strong, enabling us to grow ARR 32% YoY. I am confident that IFS is well-positioned for 2025, with a strong outlook based on the resilience we have built into the business, industry-focused innovation and our subscription-based business model."

Customer-centricity underpins consistently strong financial performance, and IFS strives for industry-leading satisfaction scores. IFS CSAT increased to over 80% in 2024, measured holistically across multiple touchpoints throughout the year and spanning the entire lifecycle, in contrast to the industry standard practise of an annual pulse check.

IFS now has the distinction of being a Gartner Peer Insights Customers' Choice across three of its core solution areas: Field Service Management, Cloud ERP for Product-Centric Enterprises, and Enterprise Asset Management. IFS was recognized as the #1 vendor on The Software Report's Top 100 Software Companies for 2024. IFS was also named the fastest growing vendor among top 10 companies in IDC Worldwide Asset Life-Cycle Management Applications Market Shares 2023 report.

IFS Press Contacts:
EUROPE / MEA / APJ:
Adam Gillbe
IFS, Director of Corporate & Executive Communications
Email:?adam.gillbe@ifs.com

NORTH AMERICA / LATAM:
Mairi Morgan
IFS, Director of Corporate & Executive Communications
Email:?mairi.morgan@ifs.com

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/ifs/r/ifs-announces-outstanding-2024-financial-results-driven-by-increase-in-demand-for-industrial-ai,c4095045

The following files are available for download:

https://news.cision.com/ifs/i/ifs-social-financials-2024-01-25v83-2,c3370610

IFS Social Financials-2024 01-25v83 2

Cision View original content:https://www.prnewswire.co.uk/news-releases/ifs-announces-outstanding-2024-financial-results-driven-by-increase-in-demand-for-industrial-ai-302358496.html

© 2025 PR Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.